Dec. 8 at 4:07 AM
$AUTL Current lupus drugs suppress the immune system indefinitely and don’t cure the disease.
CAR-T could offer:
✔ One-time treatment
✔ Long-lasting remission
✔ No ongoing medications
This is the same type of breakthrough seen in cancer — but applied to a huge market:
~1.5M people in the U.S. have lupus
Up to 70% have B-cell–driven disease
Current drugs:
$20–
$70K per year, lifelong
CAR-T pricing:
$350K+ one-time
If this works, it’s a multi-billion-dollar category — far larger than leukemia.
